查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1412721

子宮內避孕器市場：按類型、年齡層、最終用戶分類 - 全球預測 2024-2030

Intrauterine Devices Market by Type (Hormonal: Progestogen-releasing IUD, Nonhormonal: Copper-containing IUD), Age Group (15-24 Years, 25-34 Years, 35-44 Years), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

子宮內避孕器市場規模預計2023年為31.3億美元，2024年達32.4億美元，預計2030年將達42.9億美元，複合年成長率為4.59%。

全球子宮內避孕器市場

主要市場統計
基準年[2023] 31.3億美元
預測年份 [2024] 32.4億美元
預測年份 [2030] 42.9億美元
複合年成長率（%） 4.59%
子宮內避孕器市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估子宮內避孕器市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對子宮內避孕器市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-子宮內避孕器市場的市場規模和預測是多少？

2-在子宮內避孕器市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3-子宮內避孕器市場的技術趨勢和法律規範是什麼？

4-子宮內避孕器市場主要供應商的市場佔有率是多少？

5-進入子宮內避孕器市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加收養以避免意外懷孕
      • 政府和非政府組織努力推廣子宮內避孕器
    • 抑制因素
      • 擔心丟失繩子和使用子宮內避孕器帶來的感染風險
    • 機會
      • 專注於設計下一代IUD（子宮內避孕器）
      • 推出智慧子宮內避孕器
    • 任務
      • 大眾的認知和採納有限
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章子宮內避孕器市場：依類型

  • 荷爾蒙：釋放黃體素的子宮內避孕器
  • 非荷爾蒙：含銅子宮內避孕器

第7章子宮內避孕器市場：依年齡層別

  • 15-24歲
  • 25-34歲
  • 35-44歲
  • 44歲以上

第8章子宮內避孕器市場：依最終用戶分類

  • 診所
  • 社區醫療中心
  • 醫院

第9章 北美和南美子宮內避孕器市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太子宮內避孕器市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲子宮內避孕器市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第13章競爭產品組合

  • 主要公司簡介
    • Actavis Generics by Teva Pharmaceutical Industries Ltd.
    • Agile Therapeutics, Inc.
    • Allergan Plc by Abbvie Inc
    • Ava AG
    • Bayer AG
    • Cardinal Health, Inc.
    • Contrel Europe NV
    • CooperSurgical Inc.
    • Egemen International
    • ERENLER MEDIKAL SAN. TIC. LTD. STI.
    • Eurogine SL
    • Fuji Latex Co., Ltd.
    • HLL Lifecare Limited
    • HRA Pharma, SAS
    • Melbea AG
    • Merck & Co., Inc.
    • Meril Life Sciences Pvt. Ltd.
    • Mona Lisa NV
    • Mylan NV by Viatris Inc.
    • Novartis AG
    • Ocon Medical Ltd
    • Pregna International Limited
    • Prosan International BV
    • Searchlight Pharma Inc.
    • SMB Corporation of India
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-8E22B61932D7

[185 Pages Report] The Intrauterine Devices Market size was estimated at USD 3.13 billion in 2023 and expected to reach USD 3.24 billion in 2024, at a CAGR 4.59% to reach USD 4.29 billion by 2030.

Global Intrauterine Devices Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.13 billion
Estimated Year [2024] USD 3.24 billion
Forecast Year [2030] USD 4.29 billion
CAGR (%) 4.59%
Intrauterine Devices Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Intrauterine Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intrauterine Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Intrauterine Devices Market, highlighting leading vendors and their innovative profiles. These include Actavis Generics by Teva Pharmaceutical Industries Ltd., Agile Therapeutics, Inc., Allergan Plc by Abbvie Inc, Ava AG, Bayer AG, Cardinal Health, Inc., Contrel Europe NV, CooperSurgical Inc., Egemen International, ERENLER MEDIKAL SAN. TIC. LTD. STI., Eurogine S.L., Fuji Latex Co., Ltd., HLL Lifecare Limited, HRA Pharma, SAS, Melbea AG, Merck & Co., Inc., Meril Life Sciences Pvt. Ltd., Mona Lisa N.V., Mylan NV by Viatris Inc., Novartis AG, Ocon Medical Ltd, Pregna International Limited, Prosan International BV, Searchlight Pharma Inc., and SMB Corporation of India.

Market Segmentation & Coverage

This research report categorizes the Intrauterine Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Hormonal: Progestogen-releasing IUD
    • Nonhormonal: Copper-containing IUD
  • Age Group
    • 15-24 Years
    • 25-34 Years
    • 35-44 Years
    • Above 44 Years
  • End User
    • Clinics
    • Community Health Care Centres
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Intrauterine Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intrauterine Devices Market?

3. What are the technology trends and regulatory frameworks in the Intrauterine Devices Market?

4. What is the market share of the leading vendors in the Intrauterine Devices Market?

5. Which modes and strategic moves are suitable for entering the Intrauterine Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Intrauterine Devices Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising adoption to avoid unintended pregnancies
      • 5.1.1.2. Government and NGO initiatives to promote IUD
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to lost strings and risk of infection due to IUD usage
    • 5.1.3. Opportunities
      • 5.1.3.1. Focus on the design of next-generation IUD (intrauterine device)
      • 5.1.3.2. Emergence of smart intrauterine contraceptive device
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and adoption among population
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Intrauterine Devices Market, by Type

  • 6.1. Introduction
  • 6.2. Hormonal: Progestogen-releasing IUD
  • 6.3. Nonhormonal: Copper-containing IUD

7. Intrauterine Devices Market, by Age Group

  • 7.1. Introduction
  • 7.2. 15-24 Years
  • 7.3. 25-34 Years
  • 7.4. 35-44 Years
  • 7.5. Above 44 Years

8. Intrauterine Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Community Health Care Centres
  • 8.4. Hospitals

9. Americas Intrauterine Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intrauterine Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intrauterine Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Actavis Generics by Teva Pharmaceutical Industries Ltd.
    • 13.1.2. Agile Therapeutics, Inc.
    • 13.1.3. Allergan Plc by Abbvie Inc
    • 13.1.4. Ava AG
    • 13.1.5. Bayer AG
    • 13.1.6. Cardinal Health, Inc.
    • 13.1.7. Contrel Europe NV
    • 13.1.8. CooperSurgical Inc.
    • 13.1.9. Egemen International
    • 13.1.10. ERENLER MEDIKAL SAN. TIC. LTD. STI.
    • 13.1.11. Eurogine S.L.
    • 13.1.12. Fuji Latex Co., Ltd.
    • 13.1.13. HLL Lifecare Limited
    • 13.1.14. HRA Pharma, SAS
    • 13.1.15. Melbea AG
    • 13.1.16. Merck & Co., Inc.
    • 13.1.17. Meril Life Sciences Pvt. Ltd.
    • 13.1.18. Mona Lisa N.V.
    • 13.1.19. Mylan NV by Viatris Inc.
    • 13.1.20. Novartis AG
    • 13.1.21. Ocon Medical Ltd
    • 13.1.22. Pregna International Limited
    • 13.1.23. Prosan International BV
    • 13.1.24. Searchlight Pharma Inc.
    • 13.1.25. SMB Corporation of India
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. INTRAUTERINE DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. INTRAUTERINE DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. INTRAUTERINE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INTRAUTERINE DEVICES MARKET DYNAMICS
  • FIGURE 7. INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 10. INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. INTRAUTERINE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. INTRAUTERINE DEVICES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. INTRAUTERINE DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. INTRAUTERINE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. INTRAUTERINE DEVICES MARKET SIZE, BY HORMONAL: PROGESTOGEN-RELEASING IUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. INTRAUTERINE DEVICES MARKET SIZE, BY NONHORMONAL: COPPER-CONTAINING IUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 9. INTRAUTERINE DEVICES MARKET SIZE, BY 15-24 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. INTRAUTERINE DEVICES MARKET SIZE, BY 25-34 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. INTRAUTERINE DEVICES MARKET SIZE, BY 35-44 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. INTRAUTERINE DEVICES MARKET SIZE, BY ABOVE 44 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. INTRAUTERINE DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. INTRAUTERINE DEVICES MARKET SIZE, BY COMMUNITY HEALTH CARE CENTRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. INTRAUTERINE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. INTRAUTERINE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 145. INTRAUTERINE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. INTRAUTERINE DEVICES MARKET LICENSE & PRICING